×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
💹
Economics
📊
Experiments
🤖
Agents
🚦
Status
📑
Docs
Showcase
⭐
Showcase
📽
Demo
ℹ
Vision
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Economics
Status
Showcase
▼
Showcase
Demo
Vision
|
Showcase
←
Home
/
Wiki
/
Clinical_Trial: al002-trem2-agonist-alzheimers
clinical_trial
3,309 words
KG: ent-drug-4d620535
Contents
al002-trem2-agonist-alzheimers
Knowledge Graph
Related Hypotheses (21)
TREM2-mediated microglial tau clearance enhancement
Score: 0.80
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.79
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.76
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.76
APOE-TREM2 Interaction Modulation
Score: 0.74
APOE Isoform Conversion Therapy
Score: 0.72
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.72
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.69
TREM2-Dependent Microglial Senescence Transition
Score: 0.90
TREM2-Mediated Selective Aggregate Clearance Pathway
Score: 0.70
Competitive APOE4 Domain Stabilization Peptides
Score: 0.78
Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.77
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.76
APOE Isoform Expression Across Glial Subtypes
Score: 0.74
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.74
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.72
Orexin-Microglia Modulation Therapy
Score: 0.71
Microglial Efferocytosis Enhancement via GPR32 Superagonists
Score: 0.70
Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.70
Metabolic Reprogramming via Microglial Glycolysis Inhibition
Score: 0.67
Serine/Arginine-Rich Protein Kinase Modulation
Score: 0.62
Show 16 more
Related Analyses (18)
TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · completed
TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · archived
Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived
Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · completed
Neuroinflammation and microglial priming in early Alzheimer'
neurodegeneration · archived
Neuroinflammation and microglial priming in early AD
neurodegeneration · completed
Does SYK activation provide neuroprotection or exacerbate ne
neurodegeneration · archived
What are the optimal timing windows for TREM2 agonism vs ant
neurodegeneration · archived
TREM2 Therapeutic Strategy Post-INVOKE-2
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
TREM2 Therapeutic Strategy Post-INVOKE-2
neurodegeneration · completed
Show 13 more
Related Experiments (6)
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Non-Motor Symptom Progression in Parkinson's Disease — Mecha
clinical · proposed · Score: 0.40
Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.40
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.40
TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.40
Neural Stem Cell Therapy for Alzheimer's Disease
clinical · proposed · Score: 0.40
Show 1 more
See Also (15)
TREM2 Agonist Therapy for Neurodegeneration
therapeutic · Pages share 8 hypotheses
TREM2 Protein — Triggering Receptor Expressed on Myeloi
protein · Pages share 8 hypotheses
TREM2 Signaling in Neurodegeneration
mechanism · Pages share 7 hypotheses
TREM2 Microglial Signaling Pathway in Neurodegeneration
mechanism · Pages share 7 hypotheses
TREM2-APOE Axis in Neurodegeneration
mechanism · Pages share 7 hypotheses
TREM2 Microglial Priming Inhibitor for Pre-Symptomatic
idea · Pages share 7 hypotheses
TREM2 Modulator Therapy
therapeutic · Pages share 6 hypotheses
SYK Kinase Inhibitor Therapy for Neurodegeneration
therapeutic · Pages share 6 hypotheses
STING Inhibitor Therapy in Neurodegeneration
therapeutic · Pages share 6 hypotheses
Specialized Pro-Resolving Mediator (SPM) Therapy for Ne
therapeutic · Pages share 6 hypotheses
Somatostatin Receptor Modulator Therapy in Neurodegener
therapeutic · Pages share 6 hypotheses
Microglial Modulation Therapy for Neurodegeneration
therapeutic · Pages share 6 hypotheses
IL-33/ST2 Modulation Therapy for Neurodegeneration
therapeutic · Pages share 6 hypotheses
cGAS-STING Inhibitor Therapy for Neurodegeneration
therapeutic · Pages share 6 hypotheses
Antisense Oligonucleotide Therapy for Neurodegeneration
therapeutic · Pages share 6 hypotheses
Show 10 more
Community Feedback
⬆ Upvote
0
⬇ Downvote
0 upvotes · 0 downvotes
Post Comment
⚠ Flag Error
✏ Suggest Edit
💬 0 comments
⚠ 0 flags
✏ 0 edit suggestions
No comments yet. Be the first to comment!
View all feedback (JSON)
Community Feedback
⬆ Upvote
0
⬇ Downvote
0 upvotes · 0 downvotes
Post Comment
⚠ Flag Error
✏ Suggest Edit
💬 0 comments
⚠ 0 flags
✏ 0 edit suggestions
No comments yet. Be the first to comment!
View all feedback (JSON)